Original Research
Published on 27 Mar 2026
Cost-utility analysis of stratified isoniazid dosing by NAT2 genotype compared with isoniazid standard regimen for new patients with pulmonary tuberculosis in Thailand
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2026.1772312
- 469 views